Research with Recreational Cannabis in Germany - Which Agency is Responsible?

Recommendation
18-20 November 2025
Heidelberg, Germany
GMP and FDA Compliance in Pharmaceutical Development and IMP Manufacturing
In December 2024, the German Bundesgesetzblatt (Federal Law Gazette) published the Regulation determining the competent authority for issuing licenses and monitoring the handling of cannabis for scientific purposes in accordance with the German Konsumcannabisgesetz (Consumer Cannabis Act). As a result, the Bundesinstitut für Arzneimittel und Medizinprodukte (German Federal Institute for Drugs and Medical Devices, BfArM) is no longer in charge of processing research applications for recreational cannabis and industrial hemp; this responsibility now lies with the Bundesanstalt für Landwirtschaft und Ernährung (German Federal Office for Agriculture and Food, BLE).
In accordance with the regulation, the BLE will review the relevant research applications and monitor the authorized projects. Previously, this task was the responsibility of the BfArM, who will remain the competent authority for research with medicinal cannabis. Research on and with recreational cannabis is therefore possible, but requires a license. Applicants must meet the criteria set out in the Consumer Cannabis Act, demonstrate the required expertise and provide evidence of their scientific interest. Universities as well as private companies may submit research applications. The research aims to reduce the illicit market, improve public health and bring more facts to the cannabis debate.
Further information can be found in the Regulation on the determination of the competent authority for the licensing and supervision of the handling of cannabis for scientific purposes under the Consumer Cannabis Act (Konsumcannabis-Wissenschafts-Zuständigkeitsverordnung - KCanWissZustV).
Related GMP News
01.07.2025GMP non-Compliance Reports for two Cannabis Sites
01.07.2025New Ph. Eur. Chapter for Estragole Determination
01.07.2025EMA Reflection Paper on Data Recommendations for Herbal Medicinal Products
20.05.2025Update on the USP CBD Monograph
20.05.2025Proposed USP Quality Attributes for Cannabis in Clinical Investigations
02.04.2025BfArM Guideline for the Application for a Licence to Cultivate Cannabis